market access
CSL Behring’s therapy for hereditary angioedema receives positive assessment in Germany
June 26, 2025Market Access, Market Research, Medical Communications, Research and Development, Sales and Marketing CSL Behring, Institute for Quality and Efficiency in Health Care, Rare Diseases, clinical trials, hereditary angioedema, market access
CSL Behring has announced a key milestone for its hereditary angioedema (HAE) therapy, garadacimab, following a positive benefit assessment by …
AOTI achieves broad market access in Germany for diabetic foot ulcer therapy
June 23, 2025Market Access, Medical Communications, Sales and Marketing AOTI, Diabetes, European pharma market, German pharma market, Wound Healing, diabetic foot ulcers, market access, positive recommendation
AOTI, focused on solutions for severe and chronic wounds, has announced that its unique topical wound oxygen (TWO2) therapy has …
Partnership with payers: Communicating and negotiating with impact
December 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, market access, pharma
NDA’s Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising team …
Redefining the value of medicines with patients at the centre
November 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, health economics and outcomes research, market access, pharma
Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of …
Epilepsy Society calls for review of UK supply chain following “steep rise” in access issues
April 9, 2019Manufacturing and Production, Sales and Marketing Epilepsy Society, UK, brexit, epilepsy, market access, pharma
The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure …
The October 2018 issue of Pharmafocus is available to read online now!
September 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma
The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
The June 2018 issue of Pharmafocus is now live!
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma
The new June edition of Pharmafocus is now available to read online.
Brexit Health Alliance: Brexit and the impact on patient access to medicines
March 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma
On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …
FDA access programmes shaved up to a year off drug approval times, new study shows
December 7, 2017Research and Development, Sales and Marketing FDA, market access, pharma
A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could …
Refining the system: Improving patients’ access to medicine
September 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals
The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …
New game, new rules: Pathways for better and affordable medicines in Europe
June 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access
Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
Novartis signs drug access deal with Pakistan government
May 12, 2017Medical Communications, Sales and Marketing Islamabad, Novartis, Pakistan, market access
Pakistan’s Ministry of National Health Services, Regulations and Coordination has signed an agreement with Novartis to improve access to medicines …
2016 Top markets report
December 23, 2016Medical Communications market, market access
2016 Top Markets Report
GSK emerges top of the pile for improving access to medicine
November 14, 2016Medical Communications, Sales and Marketing Access to Medicine Index, GSK, market access, pricing
GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …
